Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Gaiddon

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Letters|October 20, 2018
A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53Vania Vidimar, Cynthia Licona, Ricardo Cerón-Camacho, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Frontiers in Immunology|November 29, 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancerJana Mourtada, Christelle Lony, Anaïs Nicol, et al.
Communications Biology|November 14, 2022
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancerLidan Hou, Yichao Hou, Yu Liang, et al.
Annals of Epidemiology|March 19, 2018
Use of a case-mix approach to study the trends in the incidence of second primary cancersBoris Gass, Emilie Marrer, Simona Bara, et al.
Journal of Virology|April 27, 2022
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon ExpressionJuline Poirson, Irina Paula Suarez, Marie-Laure Straub, et al.
Inorganic Chemistry|November 9, 2018
From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer AgentsNelson Y S Lam, Dianna Truong, Hilke Burmeister, et al.
Oncogene|October 11, 2019
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathwayYu Liang, Lidan Hou, Linjing Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 21, 2026
<i>In vitro</i> screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives <i>CDKN1</i> and <i>BBC3</i> expression to restore a p53-dependent cytotoxicitySimon Nannini, Céline Sieffert, Andrew McGown, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Letters|October 20, 2018
A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53Vania Vidimar, Cynthia Licona, Ricardo Cerón-Camacho, et al.
Inorganic Chemistry|February 15, 2018
Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of ActionMaria V Babak, Martin Pfaffeneder-Kmen, Samuel M Meier-Menches, et al.
Frontiers in Immunology|November 29, 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancerJana Mourtada, Christelle Lony, Anaïs Nicol, et al.
Communications Biology|November 14, 2022
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancerLidan Hou, Yichao Hou, Yu Liang, et al.
Annals of Epidemiology|March 19, 2018
Use of a case-mix approach to study the trends in the incidence of second primary cancersBoris Gass, Emilie Marrer, Simona Bara, et al.
Journal of Virology|April 27, 2022
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon ExpressionJuline Poirson, Irina Paula Suarez, Marie-Laure Straub, et al.
Inorganic Chemistry|November 9, 2018
From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer AgentsNelson Y S Lam, Dianna Truong, Hilke Burmeister, et al.
Oncogene|October 11, 2019
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathwayYu Liang, Lidan Hou, Linjing Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 21, 2026
<i>In vitro</i> screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives <i>CDKN1</i> and <i>BBC3</i> expression to restore a p53-dependent cytotoxicitySimon Nannini, Céline Sieffert, Andrew McGown, et al.
Pageof 7